Search results for “Exocrine pancreatic insufficiency” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 123 patents, we discovered top 33 key players by total patent application. Allergan Pharmaceuticals International Ltd., Eli Lilly & Co., Abbott Products SAS are dominant in this area. They take 30.08% of the total patent filing.
Ireland
Patent: 15
Indiana, United States
Patent: 13
France
Patent: 9
Vaud, Switzerland
Patent: 8
Germany
Patent: 8
Schleswig-Holstein, Germany
Patent: 5
Germany
Patent: 5
Zuid-Holland, Netherlands
Patent: 5
New Jersey, United States
Patent: 5
Jiangsu Sheng, China
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 28 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing Nordmark Pharma GmbH, Société des Produits Nestlé SA, Nordmark Arzneimittel GmbH & Co. KG take 67.86% of patent filing during this period.
Germany
Patent: 7
Vaud, Switzerland
Patent: 7
Schleswig-Holstein, Germany
Patent: 5
The Board of Regents of The University of Texas System
Texas, United States
Patent: 2
Germany
Patent: 1
Ireland
Patent: 1
Illinois, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 28 patents in last 5 years, we discover 1 new entrants.
Schleswig-Holstein, Germany
Patent: 5
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: